Acidosis and extreme hyperkalemia associated with cholestyramine and spironolactone

Abstract

View all access options for this article.

Scheel

Jr. , Whelton

, Rossiter

, Watson

Cholestyramine-induced hyperchloremic metabolic acidosis. J Clin Pharmacol 1992; 32: 536–8.

Runeberg

, Tatu

, Esko

AN.

Effect of cholestyramine on mineral excretion in man. Acta Med Scand 1972; 192: 71–6.

Rigolin

, Chap

Extreme hyperkalemia induced by drugs. Postgrad Med 1991; 90: 129–31.

Sarin

, Sachdev

, Mishra

, Sundaram

, Shrivastwa

, Talukdar

Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. Digestion 1988; 41: 101–7.

DeFronzo

, Bia

, Smith

Clinical disorders of hyperkalemia. Annu Rev Med 1982; 33: 521–54.